Skip to main content
OpenTrials
Completed

NCT Number: NCT06508411

Exploration of the Relationship Between Sexual Health and Pain in the Context of Cancer in France

The goal of this observational study is to explore the relationship between pain and sexual health in the context of cancer (cancer patients and cancer survivors). The main question it aims to answer is:

- Does pain interfere with sexual health in cancer patients and cancer survivors?

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Pain Cancer Neoplasms Nervous System Diseases Neuralgia Neurologic Manifestations Neuromuscular Diseases Pathological Conditions, Signs and Symptoms Peripheral Nervous System Diseases Signs and Symptoms Survivorship

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

CHU Clermont-Ferrand

Clermont-Ferrand, France

About this study

Participants will be recruited through French cancer patient associations and will be invited to complete an online survey questionnaire, exploring:

  • Sexual health and sexual satisfaction
  • Pain severity and impact on daily activities
  • Neuropathic pain
  • Migraine
  • Chemotherapy-induced peripheral neuropathy
  • Quality of life, functioning, and symptoms
  • Anxiety and depression
  • Sociodemographic characteristics of patients
  • Oncological characteristics

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Declaring themselves to be suffering from or having suffered from cancer recruited as such via appropriate communication systems (patient associations and social networks, etc.)

Exclusion criteria

  • No command of the French language
  • Residence outside France (verified with the department of residence in the questionnaire)
  • Patient Companion
  • Protected adult

Treatment and study plan

Pain screening

Other

exploration of the relationship between pain and sexual health

Primary outcomes

  1. presence of pain

    Time frame: day 1

    BPI-SF questionnaire - Brief Pain Inventory short from (scores from 0 to 10 worse)

  2. Sexual satisfaction

    Time frame: day 1

    SHQ-C22 questionnaire - Sexual Health Questionnaire (Scores from 0 to 100 better)

Secondary outcomes

  1. Sexual satisfaction

    Time frame: day 1

    Visual analog scale (Scores from 0 to 10 better)

  2. Quality of the sexual health

    Time frame: day 1

    SHQ-C22 questionnaire - Sexual Health Questionnaire (Scores from 0 to 100 better to worse depending of the items)

  3. Pain severity and characteristics

    Time frame: day 1

    BPI-SF questionnaire - Brief Pain Inventory short from (scores from 0 to 10 worse)

  4. Presence of neuropathic pain

    Time frame: day 1

    DN4 interview questionnaire - neuropathique pain 4 questions (scores from 0 to 7 worse)

  5. Presence of migraine

    Time frame: day 1

    Items of the International Classification of Headache Disorders (typical headache that lasted 4-72 h without treatment, at least two of four typical headache characteristics (unilateral, pulsatile, pain intensity ≥4/10 on the visual analogue scale for pain, increase in pain with physical activity), at least one of two types of non pain-associated symptoms (nausea and/or vomiting, photophobia, and phonophobia))

  6. Severity of chemotherapy-induced peripheral neuropathy (sensory and motor)

    Time frame: day 1

    QLQ-CIPN20 questionnaire - chemotherapy-induced peripheral neuropathy (scores from 0 to 100 worse)

  7. Assessment of the quality of life

    Time frame: day 1

    QLQ-C30 questionnaire - quality of life questionnaire (scores from 0 to 100 better)

  8. Assessment of the functioning dimensions

    Time frame: day 1

    QLQ-C30 questionnaire - quality of life questionnaire (scores from 0 to 100 better)

  9. Assessment of the severity of symptoms

    Time frame: day 1

    QLQ-C30 questionnaire - quality of life questionnaire (scores from 0 to 100 worse)

  10. Sociodemographic characteristics - age of patients

    Time frame: day 1

    age (years)

  11. Sociodemographic characteristics - gender

    Time frame: day 1

    male, female, non binary

  12. Sociodemographic characteristics - body mass index

    Time frame: day 1

    body mass index (kg/m²)

  13. Sociodemographic characteristics - use of alcohol, tobacco, e-cigarette, cannabis;

    Time frame: day 1

    use of alcohol, tobacco, e-cigarette, cannabis (yes / no, yearly, monthly, weekly, daily)

  14. Sociodemographic characteristics - marital status

    Time frame: day 1

    married; Single with occasional partner; Single without occasional partner

  15. Sociodemographic characteristics - socioprofesional status

    Time frame: day 1

    Farmer ; Artisan ; Merchants/entrepreneurs ; White-collar professionals ; Intermediate professions ; Employees ; Workers ; Retirees ; Unemployed individuals

  16. Sociodemographic characteristics - living area

    Time frame: day 1

    French department of living

  17. Oncological characteristics - past and/or ongoing treatment

    Time frame: day 1

    currently being treated for cancer ; treated for cancer (today in remission and completed cancer treatments) ; treated for cancer (today cancer still present and treatments against cancer stopped)

  18. Oncological characteristics - type of cancer

    Time frame: day 1

    Breast ; Prostate ; Pulmonary ; Blood ; Gynecological ; Kidney ; Colorectal ; Others

  19. Oncological characteristics - date of cancer diagnosis

    Time frame: day 1

    date (mm/yyyy)

Sponsors and collaborators

Lead sponsor

University Hospital, Clermont-Ferrand

Other

Registry information

Official study title

Exploration of the Relationship Between Sexual Health and Pain in the Context of Cancer in France: Cross-sectional Study

Acronym: CASEXPA

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Jul 18, 2024
Registry last updated
Jul 16, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.